Hesperidin downregulates kinases lrrk2 and gsk3β in a 6-OHDA induced Parkinson’s disease model
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 740, 135426
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology
This publication has 47 references indexed in Scilit:
- Activation of GSK-3β and Caspase-3 Occurs in Nigral Dopamine Neurons during the Development of Apoptosis Activated by a Striatal Injection of 6-HydroxydopaminePLOS ONE, 2013
- Polyphenols: Multipotent Therapeutic Agents in Neurodegenerative DiseasesOxidative Medicine and Cellular Longevity, 2013
- High Glucose-Induced Oxidative Stress Increases the Copy Number of Mitochondrial DNA in Human Mesangial CellsBioMed Research International, 2013
- Genetics of Parkinson's DiseaseCold Spring Harbor Perspectives in Medicine, 2012
- A Guide to Neurotoxic Animal Models of Parkinson's DiseaseCold Spring Harbor Perspectives in Medicine, 2011
- Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic miceNeurobiology of Disease, 2010
- Polyphenols and Human Health: Prevention of Disease and Mechanisms of ActionNutrients, 2010
- The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?Trends in Neurosciences, 2008
- Oxidative Stress and NeurotoxicityChemical Research in Toxicology, 2007
- Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTPCell and tissue research, 2004